FDA Inspection 1134218 — Andrew T Catanzaro, MD
The FDA completed an inspection of Andrew T Catanzaro, MD on December 2, 2020 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 2, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Silver Spring, MD (United States)
Additional Details
Clinical Investigator (CI)